EssilorLuxottica, a global leader in the optical industry, is revolutionizing myopia management with its cutting-edge Essilor Stellest platform. At the China International Import Expo (CIIE) in Shanghai, the company unveiled significant advancements in myopia management, showcasing its commitment to addressing the growing concern of myopia among children worldwide.
The Essilor Stellest 2.0 lenses are a breakthrough in myopia management, offering a highly effective solution to slow down the progression of myopia. These lenses have been clinically proven to generate a stronger optical signal, delivering double the mean optical power compared to previous models. This innovation builds upon the success of the Essilor Stellest lens, the first FDA-authorized spectacle lens to slow myopia progression in children.
Essilor Stellest 2.0 lenses are now available in Greater China, with plans to expand to other key markets in 2026. This expansion is a testament to the company's dedication to making these advanced lenses accessible to those who need them most.
Furthermore, EssilorLuxottica introduced the Essilor Stellest Smartglasses, a groundbreaking innovation in the field of myopia management. These smart glasses, equipped with Essilor Stellest lenses, track wearing time and patterns, providing valuable behavioral insights. This technology is crucial for ensuring compliance with prescribed wearing schedules, which is essential for the efficiency of myopia management.
The Essilor Stellest Smartglasses will be available in Mainland China starting in Q1 2026, marking a significant step forward in the integration of smart technology with myopia management. This development is particularly exciting as it combines the power of advanced lens technology with the convenience and insights of smart glasses.
EssilorLuxottica's commitment to innovation and evidence-based prevention is evident in its latest offerings. By combining advanced lens technology with smart features, the company aims to enable early intervention, promote healthy wearing habits, and accelerate progress in slowing myopia progression in children. This holistic approach to myopia management is a significant step towards empowering the next generation with better eye health.
In conclusion, EssilorLuxottica's Essilor Stellest platform is a game-changer in myopia management, offering innovative solutions that are clinically proven and accessible. With the introduction of Essilor Stellest 2.0 lenses and Essilor Stellest Smartglasses, the company is well-positioned to make a substantial impact on the lives of children worldwide, ensuring they have access to the best possible eye care solutions.
